MoneyWorks4Me

Hikal - Quaterly Results

07 Aug 2025 Evaluate
The sales slipped to Rs. 3804.00 millions for the June 2025 quarter as against Rs. 4068.00 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -227.00 millions as compared to Net Profit of Rs. 52.00 millions of corresponding quarter ended June 2024Operating Profit reported a sharp decline to 258.00 millions from 586.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 3804.00 4068.00 -6.49 3804.00 4068.00 -6.49 18598.00 17846.00 4.21
Other Income 10.00 5.00 100.00 10.00 5.00 100.00 50.00 25.00 100.00
PBIDT 258.00 586.00 -55.97 258.00 586.00 -55.97 3335.00 2694.00 23.79
Interest 171.00 198.00 -13.64 171.00 198.00 -13.64 752.00 564.00 33.33
PBDT 87.00 388.00 -77.58 87.00 388.00 -77.58 2583.00 2130.00 21.27
Depreciation 394.00 318.00 23.90 394.00 318.00 23.90 1344.00 1176.00 14.29
PBT -307.00 70.00 -538.57 -307.00 70.00 -538.57 1239.00 954.00 29.87
TAX -80.00 18.00 -544.44 -80.00 18.00 -544.44 330.00 259.00 27.41
Deferred Tax -80.00 3.00 -2766.67 -80.00 3.00 -2766.67 30.00 -25.00 -220.00
PAT -227.00 52.00 -536.54 -227.00 52.00 -536.54 909.00 695.00 30.79
Equity 247.00 247.00 0.00 247.00 247.00 0.00 247.00 247.00 0.00
PBIDTM(%) 6.78 14.41 -52.92 6.78 14.41 -52.92 17.93 15.10 18.79
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..